Pathway Financial Advisers LLC Sells 215 Shares of MetLife, Inc. (NYSE:MET)

Pathway Financial Advisers LLC reduced its stake in MetLife, Inc. (NYSE:MET) by 0.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,096 shares of the financial services provider’s stock after selling 215 shares during the quarter. Pathway Financial Advisers LLC’s holdings in MetLife were worth $2,137,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. CWM LLC increased its stake in MetLife by 15.0% in the third quarter. CWM LLC now owns 18,256 shares of the financial services provider’s stock valued at $1,506,000 after acquiring an additional 2,383 shares during the last quarter. Ritholtz Wealth Management bought a new position in shares of MetLife during the 3rd quarter valued at about $214,000. Thurston Springer Miller Herd & Titak Inc. increased its position in shares of MetLife by 54.5% during the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 757 shares of the financial services provider’s stock valued at $62,000 after purchasing an additional 267 shares during the last quarter. CX Institutional raised its holdings in shares of MetLife by 703.9% during the 3rd quarter. CX Institutional now owns 58,668 shares of the financial services provider’s stock valued at $4,839,000 after buying an additional 51,370 shares in the last quarter. Finally, Creative Planning lifted its position in MetLife by 3.1% in the 3rd quarter. Creative Planning now owns 130,967 shares of the financial services provider’s stock worth $10,802,000 after buying an additional 3,964 shares during the last quarter. Institutional investors own 94.99% of the company’s stock.

MetLife Stock Performance

MetLife stock opened at $82.77 on Thursday. MetLife, Inc. has a fifty-two week low of $67.04 and a fifty-two week high of $89.05. The stock has a market cap of $57.31 billion, a price-to-earnings ratio of 13.86, a PEG ratio of 0.64 and a beta of 1.07. The stock’s 50 day simple moving average is $83.54 and its two-hundred day simple moving average is $81.00. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.16 and a current ratio of 0.16.

MetLife (NYSE:MET) last announced its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 EPS for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a net margin of 6.19% and a return on equity of 20.42%. As a group, analysts expect that MetLife, Inc. will post 9.63 earnings per share for the current fiscal year.

MetLife Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be given a $0.545 dividend. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.63%. MetLife’s dividend payout ratio is currently 36.52%.

Analyst Upgrades and Downgrades

MET has been the topic of a number of recent research reports. StockNews.com cut shares of MetLife from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. Barclays reduced their target price on shares of MetLife from $96.00 to $95.00 and set an “overweight” rating on the stock in a report on Friday, February 7th. Wells Fargo & Company lowered their price target on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a research note on Tuesday, January 14th. TD Cowen boosted their target price on MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday, November 27th. Finally, JPMorgan Chase & Co. boosted their price objective on MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Two analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $92.17.

MetLife Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.